相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials
K. Reich et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Long-term efficacy of ustekinumab in moderate-to-severe psoriasis
A. B. Kimball et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients from REVEAL
Kenneth Gordon et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Efficacy of systemic therapies for moderate-to-severe psoriasis: a systematic review and meta-analysis of long-term treatment
T. C. Lucka et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2012)
Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies
K. Reich et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Adalimumab for moderate to severe chronic plaque psoriasis: efficacy and safety of retreatment and disease recurrence following withdrawal from therapy
K. Papp et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Association Between Biologic Therapies for Chronic Plaque Psoriasis and Cardiovascular Events A Meta-analysis of Randomized Controlled Trials
Caitriona Ryan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Psoriasis and Vascular Disease-Risk Factors and Outcomes: A Systematic Review of the Literature
Rita V. Patel et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2011)
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
Craig L. Leonardi et al.
LANCET (2008)
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial
S Tyring et al.
LANCET (2006)
Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial
K Reich et al.
LANCET (2005)
Validation of immunoassays used to assess immunogenicity to therapeutic monoclonal antibodies
D Geng et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2005)
分享论文
